List of Tables
Table 1. Global Antiviral Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Generic Drugs
Table 3. Key Players of Branded Drugs
Table 4. Global Antiviral Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Antiviral Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Antiviral Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Antiviral Therapy Market Share by Region (2019-2024)
Table 8. Global Antiviral Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Antiviral Therapy Market Share by Region (2025-2030)
Table 10. Antiviral Therapy Market Trends
Table 11. Antiviral Therapy Market Drivers
Table 12. Antiviral Therapy Market Challenges
Table 13. Antiviral Therapy Market Restraints
Table 14. Global Antiviral Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Antiviral Therapy Market Share by Players (2019-2024)
Table 16. Global Top Antiviral Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Therapy as of 2023)
Table 17. Ranking of Global Top Antiviral Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Antiviral Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antiviral Therapy Product Solution and Service
Table 21. Date of Enter into Antiviral Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antiviral Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Antiviral Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global Antiviral Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Antiviral Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global Antiviral Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Antiviral Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global Antiviral Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Antiviral Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America Antiviral Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Antiviral Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Antiviral Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Antiviral Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Antiviral Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Antiviral Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Antiviral Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Antiviral Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Antiviral Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Antiviral Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Antiviral Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Antiviral Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Antiviral Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Antiviral Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Antiviral Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. AbbVie Inc. Company Detail
Table 47. AbbVie Inc. Business Overview
Table 48. AbbVie Inc. Antiviral Therapy Product
Table 49. AbbVie Inc. Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 50. AbbVie Inc. Recent Development
Table 51. Abbott Company Detail
Table 52. Abbott Business Overview
Table 53. Abbott Antiviral Therapy Product
Table 54. Abbott Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. F. Hoffmann-La Roche Ltd Company Detail
Table 57. F. Hoffmann-La Roche Ltd Business Overview
Table 58. F. Hoffmann-La Roche Ltd Antiviral Therapy Product
Table 59. F. Hoffmann-La Roche Ltd Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 60. F. Hoffmann-La Roche Ltd Recent Development
Table 61. Bristol-Myers Squibb Company Company Detail
Table 62. Bristol-Myers Squibb Company Business Overview
Table 63. Bristol-Myers Squibb Company Antiviral Therapy Product
Table 64. Bristol-Myers Squibb Company Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 65. Bristol-Myers Squibb Company Recent Development
Table 66. Johnson & Johnson Services, Inc. Company Detail
Table 67. Johnson & Johnson Services, Inc. Business Overview
Table 68. Johnson & Johnson Services, Inc. Antiviral Therapy Product
Table 69. Johnson & Johnson Services, Inc. Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 70. Johnson & Johnson Services, Inc. Recent Development
Table 71. Merck & Co., Inc. Company Detail
Table 72. Merck & Co., Inc. Business Overview
Table 73. Merck & Co., Inc. Antiviral Therapy Product
Table 74. Merck & Co., Inc. Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 75. Merck & Co., Inc. Recent Development
Table 76. Gilead Sciences, Inc. Company Detail
Table 77. Gilead Sciences, Inc. Business Overview
Table 78. Gilead Sciences, Inc. Antiviral Therapy Product
Table 79. Gilead Sciences, Inc. Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 80. Gilead Sciences, Inc. Recent Development
Table 81. GlaxoSmithKline plc Company Detail
Table 82. GlaxoSmithKline plc Business Overview
Table 83. GlaxoSmithKline plc Antiviral Therapy Product
Table 84. GlaxoSmithKline plc Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 85. GlaxoSmithKline plc Recent Development
Table 86. Aurobindo Pharma Company Detail
Table 87. Aurobindo Pharma Business Overview
Table 88. Aurobindo Pharma Antiviral Therapy Product
Table 89. Aurobindo Pharma Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 90. Aurobindo Pharma Recent Development
Table 91. AstraZeneca Company Detail
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Antiviral Therapy Product
Table 94. AstraZeneca Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiviral Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antiviral Therapy Market Share by Type: 2023 VS 2030
Figure 3. Generic Drugs Features
Figure 4. Branded Drugs Features
Figure 5. Global Antiviral Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Antiviral Therapy Market Share by Application: 2023 VS 2030
Figure 7. HIV Case Studies
Figure 8. Hepatitis Case Studies
Figure 9. Herpes Case Studies
Figure 10. Virus Influenza Case Studies
Figure 11. Others Case Studies
Figure 12. Antiviral Therapy Report Years Considered
Figure 13. Global Antiviral Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Antiviral Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Antiviral Therapy Market Share by Region: 2023 VS 2030
Figure 16. Global Antiviral Therapy Market Share by Players in 2023
Figure 17. Global Top Antiviral Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Therapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Antiviral Therapy Revenue in 2023
Figure 19. North America Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Antiviral Therapy Market Share by Country (2019-2030)
Figure 21. United States Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Antiviral Therapy Market Share by Country (2019-2030)
Figure 25. Germany Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Antiviral Therapy Market Share by Region (2019-2030)
Figure 33. China Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Antiviral Therapy Market Share by Country (2019-2030)
Figure 41. Mexico Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Antiviral Therapy Market Share by Country (2019-2030)
Figure 45. Turkey Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. AbbVie Inc. Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 48. Abbott Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 49. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 51. Johnson & Johnson Services, Inc. Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 52. Merck & Co., Inc. Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 53. Gilead Sciences, Inc. Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 54. GlaxoSmithKline plc Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 55. Aurobindo Pharma Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 56. AstraZeneca Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed